IL9 recombinant protein product blog
Tags: IL-9; Recombinant Protein; IL9; IL9 recombinant protein;
The IL9 il9 (Catalog #MBS844207) is an Active Protein produced from E Coli and is intended for research purposes only. The product is available for immediate purchase. MyBioSource\'s IL-9 can be used in a range of immunoassay formats including, but not limited to, SDS-PAGE; HPLC. Researchers should empirically determine the suitability of the IL9 il9 for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process.The IL9 il9 product has the following accession number(s) (GI #10834980) (NCBI Accession #NP_000581.1) (Uniprot Accession #P15248). Researchers may be interested in using Bioinformatics databases such as those available at The National Center for Biotechnology Information (NCBI) website for more information about accession numbers and the proteins they represent. Even researchers unfamiliar with bioinformatics databases will find the NCBI databases to be quite user friendly and useful. The amino acid sequence is listed below:
MQGCPTLAGI LDINFLINKM QEDPASKCHC SANVTSCLCL GIPSDNCTRP CFSERLSQMT NTTMQTRYPL IFSRVKKSVE VLKNNKCPYF SCEQPCNQTT AGNALTFLKS LLEIFQKEKM RGMRGKI.
To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
Our knowledge of the role of proteins in cellular processes is continually evolving. Most proteins, including IL-9 are typically involved in one or more signaling pathways or biological processes. Professionally manufactured recombinant proteins are increasingly becoming essential and commonplace tools for elucidating new knowledge about the role of proteins in both health and disease.
Solubility/Reconstitution Instructions: It is recommended to reconstitute the lyophilized product with sterile water at a concentration of 0.1 mg/ml, which can be further diluted into other aqueous solutions.
Endotoxin Level: <0.01 ng/mug
Biological Activity: The ED?? as determined by the dose-dependent proliferation of human MO7e cells, is 0.5 -0.7 ng/ml.
Results: <0.5-0.7 ng/ml
Handling: Centrifuge the vial prior to opening. Dermatitis, Eye Diseases, Heart Diseases, Hyperplasia, Hypersensitivity, Immune System Diseases, Inflammation, Liver Diseases, Lung Diseases, Necrosis are some of the diseases may be linked to IL-9, human recombinant. Kidney tissues are correlated with this protein. IL9 also interacts with the following gene(s): CCL11, IL13, IL2, IL3, IL4, IL4R, IL5, IL9R, MUC5AC.